Furthermore, in lung adenocarcinoma, menin and polycomb-mediated repression of PTN transcription and is proposed as an epigenetic mechanism that controls the PTN–ALK signaling pathway and hence can inhibit lung cancer progression (Gao et al., 2009). This evidence concerns the gene ALK and lung carcinoma.